Follow
Dominika Piasecka
Dominika Piasecka
Verified email at gumed.edu.pl
Title
Cited by
Cited by
Year
MicroRNAs in regulation of triple-negative breast cancer progression
D Piasecka, M Braun, R Kordek, R Sadej, H Romanska
Journal of cancer research and clinical oncology 144, 1401-1411, 2018
1812018
FGFR2-driven signaling counteracts tamoxifen effect on ERα-positive breast cancer cells
L Turczyk, K Kitowska, M Mieszkowska, K Mieczkowski, D Czaplinska, ...
Neoplasia 19 (10), 791-804, 2017
522017
Aspects of progesterone receptor (PR) activity regulation-impact on breast cancer progression
D Piasecka, AC Składanowski, R Kordek, HM Romańska, R Sądej
Postepy biochemii 61 (2), 198-206, 2015
452015
FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors–implications for therapy of luminal breast cancer
D Piasecka, M Braun, K Kitowska, K Mieczkowski, R Kordek, R Sadej, ...
Journal of Experimental & Clinical Cancer Research 38, 1-12, 2019
402019
Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells
D Piasecka, K Kitowska, D Czaplinska, K Mieczkowski, M Mieszkowska, ...
Oncotarget 7 (52), 86011, 2016
232016
Tetraspanin CD151 impairs heterodimerization of ErbB2/ErbB3 in breast cancer cells
M Mieszkowska, D Piasecka, P Potemski, S Debska-Szmich, ...
Translational Research 207, 44-55, 2019
132019
Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli
D Piasecka, M Braun, M Mieszkowska, L Kowalczyk, J Kopczynski, ...
Neoplasia 22 (11), 576-589, 2020
122020
Hormonal receptor status determines prognostic significance of FGFR2 in invasive breast carcinoma
M Braun, D Piasecka, B Tomasik, K Mieczkowski, K Stawiski, A Zielinska, ...
Cancers 12 (9), 2713, 2020
82020
FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
K Mieczkowski, K Kitowska, M Braun, B Galikowska‐Bogut, ...
Molecular oncology 16 (15), 2823-2842, 2022
52022
Ossifying fasciitis at an extraordinary site–a case report and analysis of diagnostic pitfalls
Ł Kowalczyk, M Braun, B Tomasik, D Piasecka, D Michno, J Fijuth, ...
Contemporary Oncology/Współczesna Onkologia 23 (2), 121-125, 2019
42019
Aspekty regulacji aktywności receptora progesteronu (PR)-znaczenie w progresji raka gruczołu piersiowego
D Piasecka, A Składanowski, R Kordek, HM Romańska, R Sądej
Postępy Biochemii 61 (2), 2015
42015
A ‘real-life’experience on automated digital image analysis of FGFR2 immunohistochemistry in breast cancer
M Braun, D Piasecka, M Bobrowski, R Kordek, R Sadej, HM Romanska
Diagnostics 10 (12), 1060, 2020
22020
Progesterone impairs Herceptin effect on breast cancer cells
K Kitowska, A Kowalska, M Mieszkowska, D Piasecka, AC Skladanowski, ...
Oncology Letters 15 (2), 1817-1822, 2018
22018
Subtype-specific tumour immune microenvironment in risk of recurrence of ductal carcinoma in situ: prognostic value of HER2
J Solek, J Chrzanowski, A Cieslak, A Zielinska, D Piasecka, M Braun, ...
Biomedicines 10 (5), 1061, 2022
12022
The diagnostic challenge in pulmonary tumour embolism in cancer: a case report and literature review
A Zielińska, M Braun, D Piasecka, P Minc, HM Romańska
Contemporary Oncology/Współczesna Onkologia 24 (4), 258-262, 2020
12020
Upregulation of HIF1-a via an NF-jB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli
D Piasecka, M Braun, M Mieszkowska, Ł Kowalczyk, J Kopczynski, ...
Neoplasia 22 (11), 2020
2020
Inflammatory stimuli promote proliferative dominance of basal-like mammary epithelial cells
D Piasecka, M Mieszkowska, M Braun, R Kordek, R Sadej, ...
European Journal of Surgical Oncology 44, S29, 2018
2018
CD151 regulates activity of ERBB receptors
M Mieszkowska, D Piasecka, P Potemski, R Sadej, HM Romanska
Acta Biochimica Polonica 65 (S2), 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–18